Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5226
Immatics
IMTX
$1.18B
| $103K | ﹤0.01% |
+6,530
| New | +$80.1K |
|
5227
Pluri
PLUR
$16.7M
| $103K | ﹤0.01% |
1,466
+930
| +174% | +$60.8K |
|
|
ABFL
5228
Abacus FCF Leaders ETF
ABFL
$520M
| $103K | ﹤0.01% |
2,743
+743
| +37% | +$26.2K |
|
|
FNGA
5229
DELISTED
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038
FNGA
| $103K | ﹤0.01% |
+1,100
| New | +$78.1K |
|
|
SURF
5230
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $103K | ﹤0.01% |
15,600
+4,228
| +37% | +$15.3K |
|
|
AGRX
5231
DELISTED
Agile Therapeutics
AGRX
| $103K | ﹤0.01% |
19
+17
| +850% | +$88.3K |
|
5232
HF Foods Group
HFFG
$80.2M
| $102K | ﹤0.01% |
11,335
+9,634
| +566% | +$70.1K |
|
|
PCM
5233
PCM Fund
PCM
$69.3M
| $102K | ﹤0.01% |
10,880
-4,815
| -31% | -$43.1K |
|
5234
XBiotech
XBIT
$68M
| $102K | ﹤0.01% |
7,424
-1,022
| -12% | -$14.4K |
|
5235
Direxion Daily CSI 300 China A Share Bull 2X ETF
CHAU
$89.3M
| $101K | ﹤0.01% |
4,434
-605
| -12% | -$12K |
|
|
FORTY
5236
Formula Systems
FORTY
$1.66B
| $101K | ﹤0.01% |
1,351
| – | – |
|
5237
UFP Technologies
UFPT
$1.97B
| $101K | ﹤0.01% |
2,276
+1,719
| +309% | +$73.5K |
|
|
EGPT
5238
DELISTED
VanEck Egypt Index ETF
EGPT
| $101K | ﹤0.01% |
4,338
-52
| -1% | -$1.16K |
|
|
DHY
5239
Credit Suisse High Yield Credit Fund
DHY
$242M
| $100K | ﹤0.01% |
49,940
-7,644
| -13% | -$14.5K |
|
5240
First Northwest Bancorp
FNWB
$109M
| $100K | ﹤0.01% |
8,069
+841
| +12% | +$9.88K |
|
|
IRL
5241
DELISTED
NEW IRELAND FUND INC
IRL
| $100K | ﹤0.01% |
12,851
| – | – |
|
5242
Citizens
CIA
$239M
| $99K | ﹤0.01% |
16,624
+11,598
| +231% | +$66.6K |
|
5243
GSI Technology
GSIT
$215M
| $99K | ﹤0.01% |
13,798
+3,264
| +31% | +$23.7K |
|
|
KNDI
5244
Kandi Technologies Group
KNDI
$67.5M
| $99K | ﹤0.01% |
23,647
-196,292
| -89% | -$647K |
|
5245
Oppenheimer Holdings
OPY
$1.14B
| $99K | ﹤0.01% |
4,567
+2,860
| +168% | +$57.9K |
|
5246
Sprott Junior Gold Miners ETF
SGDJ
$267M
| $99K | ﹤0.01% |
2,600
+2,200
| +550% | +$71K |
|
5247
Smith Micro Software
SMSI
$14.5M
| $99K | ﹤0.01% |
554
+411
| +287% | +$74.3K |
|
5248
Transact Technologies
TACT
$53.2M
| $99K | ﹤0.01% |
21,582
-342
| -2% | -$1.44K |
|
5249
Value Line
VALU
$321M
| $99K | ﹤0.01% |
3,660
+1,160
| +46% | +$33.2K |
|
5250
Select Water Solutions
WTTR
$2.3B
| $99K | ﹤0.01% |
20,334
+9,077
| +81% | +$41.6K |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.